## Distinguishing Ipratropium from Atropine ### Structural Chemistry and Absorption **Key Point:** The quaternary vs. tertiary amine distinction determines whether a drug acts systemically or locally, making it the critical discriminator for clinical safety and efficacy. **High-Yield:** - **Ipratropium**: Quaternary ammonium compound → **highly polar** → **poor GI and systemic absorption** → remains in respiratory tract → **local bronchodilation only** → minimal systemic anticholinergic effects - **Atropine**: Tertiary amine → **lipophilic** → **high systemic absorption** → distributes widely → **systemic anticholinergic effects** (mydriasis, tachycardia, urinary retention, CNS effects) ### Comparative Table | Feature | Ipratropium | Atropine | | --- | --- | --- | | Chemical class | Quaternary ammonium | Tertiary amine | | Polarity | Highly polar | Lipophilic | | Systemic absorption | Poor (< 2%) | High (80–90%) | | Site of action | Local (respiratory) | Systemic | | Mydriasis | No | Yes | | Tachycardia | Minimal | Yes | | CNS effects | None | Yes (at high doses) | | Route | Inhaled (aerosol) | Oral, IV, IM, SC | | Clinical use | COPD, asthma | Anticholinergic toxidrome, premedication, bradycardia | ### Clinical Pearl **Ipratropium's poor systemic absorption** is intentional — it allows targeted bronchodilation in the lungs without the unwanted systemic anticholinergic side effects (dry mouth, blurred vision, urinary retention) that would limit its use in elderly patients with comorbidities. ### Mnemonic **QUAT** = **Q**uaternary **U**ndergo **A**bsorption **T**roubles (poor absorption) → local action only. [cite:KD Tripathi 8e Ch 6]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.